The Greater Cannabis Company, Inc. (GCAN) は上場企業です ヘルスケア セクターの Drug Manufacturers - Specialty & Generic 業界で事業展開. 本社所在地は Baltimore, MD, アメリカ. 現CEOは Aitan Zacharin.
GCAN を有する IPO日 2018-09-18, 1 名の正社員, に上場 Other OTC, 時価総額 $188.15K.
The Greater Cannabis Company, Inc. engages in the development and commercialization of cannabinoid therapeutics. It offers an oral transmucosal patch platform, which provides loaded actives absorbed by the buccal mucosa into the body. The company was founded in 2014 and is based in Baltimore, Maryland.
